U.S. FDA Issues Complete Response Letter for Baricitinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to U.S. FDA Issues Complete Response Letter for Baricitinib

Incyte (INCY) PT Lowered to $148 at Jefferies Following CRL

April 17, 2017 6:44 AM EDT

Jefferies lowered its price target on Incyte (NASDAQ: INCY) to $148.00 (from $165.00) while maintaining a Buy rating after the "surprising" CRL on Olumiant.

Analyst Brian Abrahams said while there could be many possibilities for the FDA issue their best guess is... More